Literature DB >> 9444681

A ten-year review of the validity and clinical utility of depression screening.

C P Schade1, E R Jones, B J Wittlin.   

Abstract

OBJECTIVE: Use of depression screening instruments in primary care is controversial. The authors reviewed research studies published since the development of national practice guidelines to determine whether new evidence might favor screening. The review focused on evidence-related validity and clinical utility of depression screening instruments.
METHODS: Silver Platter MEDLINE was searched for English-language studies of depression screening instruments published between 1986 and 1995. Studies were classified by type--reviews of studies, outcome studies, validation studies. RESULTS AND
CONCLUSIONS: Fifty-nine studies met criteria for review. Validation studies were the most frequent type (39 studies) and were subclassified according to population, type of comparison, and analytical method. These studies documented the validity of screening instruments compared with formal criteria and demonstrated consistently better performance for systematic approaches compared with clinical impressions. Thirteen studies were reviews; those reviewing evidence for effectiveness disagreed in their conclusions. Only seven outcome studies related to depression screening instruments were found, and none showed measurable benefit in a screened population. Several studies showed that very brief instruments performed about as well as longer, well-validated questionnaires for screening in general populations.

Entities:  

Mesh:

Year:  1998        PMID: 9444681     DOI: 10.1176/ps.49.1.55

Source DB:  PubMed          Journal:  Psychiatr Serv        ISSN: 1075-2730            Impact factor:   3.084


  13 in total

1.  Expert opinion on detecting and treating depression in palliative care: A Delphi study.

Authors:  Lauren Rayner; Annabel Price; Matthew Hotopf; Irene J Higginson
Journal:  BMC Palliat Care       Date:  2011-05-27       Impact factor: 3.234

2.  The effectiveness of case-finding for mental health problems in primary care.

Authors: 
Journal:  Br J Gen Pract       Date:  2005-09       Impact factor: 5.386

Review 3.  The treatment of depression in cancer patients: a systematic review.

Authors:  Gary Rodin; Nancy Lloyd; Mark Katz; Esther Green; Jean A Mackay; Rebecca K S Wong
Journal:  Support Care Cancer       Date:  2006-10-21       Impact factor: 3.603

4.  Prevalence and correlates of clinically significant depressive symptoms in an urban hospital emergency department.

Authors:  Matthew J Mimiaga; William M Reichmann; Steven A Safren; Elena Losina; Christian Arbelaez; Rochelle P Walensky
Journal:  Prim Care Companion J Clin Psychiatry       Date:  2010

5.  A prospective study of depression among adult patients in an urban emergency department.

Authors:  Edwin D Boudreaux; Consuelo Cagande; Hope Kilgannon; Anita Kumar; Carlos A Camargo
Journal:  Prim Care Companion J Clin Psychiatry       Date:  2006

6.  The Comorbidity of Major Depression and Anxiety Disorders: Recognition and Management in Primary Care.

Authors:  Robert M. A. Hirschfeld
Journal:  Prim Care Companion J Clin Psychiatry       Date:  2001-12

7.  Screening for depression in primary care: will one or two items suffice?

Authors:  Verena Henkel; Roland Mergl; James C Coyne; Ralf Kohnen; Hans-Jürgen Möller; Ulrich Hegerl
Journal:  Eur Arch Psychiatry Clin Neurosci       Date:  2004-08       Impact factor: 5.270

Review 8.  Depression and HIV/AIDS.

Authors:  Tami D Benton
Journal:  Curr Psychiatry Rep       Date:  2008-06       Impact factor: 5.285

9.  Treatment of depression in cancer patients.

Authors:  G Rodin; M Katz; N Lloyd; E Green; J A Mackay; R K S Wong
Journal:  Curr Oncol       Date:  2007-10       Impact factor: 3.677

10.  Randomized comparison of the effects of the vitamin D3 adequate intake versus 100 mcg (4000 IU) per day on biochemical responses and the wellbeing of patients.

Authors:  Reinhold Vieth; Samantha Kimball; Amanda Hu; Paul G Walfish
Journal:  Nutr J       Date:  2004-07-19       Impact factor: 3.271

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.